Next-generation sequencing (NGS) technology, which has been used at Illumina since 2007, builds upon earlier genome sequencing methods to greatly reduce the time taken to sequence DNA. When the ...

"We made a patterned flow cell using a more cost-efficient manufacturing process to help drive sequencing costs down. We've had these big step changes in the industry driven by Illumina.

In the rapidly evolving field of genomics, sequencing technologies play a crucial role in advancing our understanding of genetic material. Among the most prominent methods are Illumina sequencing and ...

Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...

Roche missed out on acquiring next-generation sequencing (NGS) specialist Illumina via a hostile takeover a few years back, but has compensated for that with a 15-year alliance focusing on cancer ...

"Sequencing technology has really improved clinical outcomes in terms of risk stratification and diagnostic decisions for cancer," says Illumina bioinformatician Weida Gong. "For acute myeloid ...